Drawing for MLC

USPTO serial 79458614

MLC

Reviewed by CopyMark Law Group

Status 640Office Action
Filing date
Status date
Registration date
—
Examiner
DUBRAY, KATHERINE M
Law office
TMO LAW OFFICE 118

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 640: Status 640 means the examining attorney has prepared a non-final Office Action but it has not been mailed or e-mailed yet. The action should appear in TSDR soon, and a response deadline will start once it is issued.

Need help with MLC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer operating programs, recorded; computer software, recorded; computer software for use with glucose sensors namely, software for recording, analyzing, reporting and managing patient glucose levels; computer software for recording, analyzing, reporting and managing patient medical information; electronic publications, downloadable; computer programs, downloadable; personal digital assistants [PDA]; software as a medical device [SaMD], downloadable; downloadable software in the nature of a mobile application for use in the electronic transmission of patient medical information; downloadable computer software for use in the electronic transmission of patient glucose level and related glucose level data; computer software for use in calculating, reviewing, analyzing and displaying patient data; smart watches; electronic key fobs being remote control apparatus; electronic numeric displays; light-emitting electronic pointers; laptop computers; tablet computers; interactive touch screen terminals; software used for the management of diabetes; software for use with glucose sensors; glucose reporting software; software for use with glucose monitoring systems; mobile software applications in the field of diabetes managementACTIVE—
010Medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices, sold therewith; medical devices, namely, medical sensors that are implanted or inserted into the human body used to continuously measure and monitor the concentration of glucose in the human body and accessories therefor, namely, receivers, sensor housings and sensor insertion devices that permit the wireless reporting and analysis of the concentration of glucose in the human body sold therewith; integrated medical examination systems comprising medical devices in the nature of glycemic management; probes for medical purposes; pumps for medical purposes; injectors for medical purposes; glucose meters; diagnostic apparatus for medical purposes; testing apparatus for medical purposes; blood testing apparatus; medical diagnostic instruments for the analysis of body fluids; diagnostic instruments for medical purposes used for analyzing body fluids; diabetic monitoring apparatus; body composition monitors; trocars; needles for medical purposes; hypodermic syringes; syringes for medical purposes; medical analysis instruments; cholesterol meters; medical apparatus and instruments for diabetes management; medical apparatus and instruments for monitoring glucose; sensor-based glucose monitors; glucose meters; instruments for monitoring glucose; continuous glucose monitoring systemsACTIVE—
042Medical research services; conducting clinical trials; medical research laboratory services; medical research laboratory services for the analysis of samples taken from patients; scientific analysis and research services; product development relating to pharmaceuticals, medicines, medicaments and veterinary products; cloud computing featuring computer application software for mobile phones, handheld computers, desktop computers, laptop computers, namely, software for recording, analyzing, reporting and managing patient glucose levels; provision of non-downloadable computer software for recording, analyzing, reporting and managing patient health and medical information; cloud computing featuring computer application software; cloud computing featuring computer application software for third parties to access patient glucose levels and patient health and medical information; cloud computing featuring computer application software for recording, analyzing, reporting and managing patient glucose levels and patient health and medical information; software as a service (SaaS) services featuring software for mobile phones, handheld computers, desktop computers, laptop computers, namely, software for mobile phones, handheld computers, desktop computers, laptop computers, namely, software for third parties to access patient glucose levels and patient health and medical information; software as a service (SaaS) services featuring software for mobile phones, handheld computers, desktop computers, laptop computers, namely, software for recording, analyzing, reporting and managing patient glucose levels, related glucose level data and patient health and medical information; software as a service (SaaS) services featuring software for recording, analyzing, reporting and managing patient health and medical information; providing glucose reporting software services and cloud platform services featuring software for sharing, reporting, maintaining, managing, monitoring and analyzing of medical information in the field of diabetes management; providing temporary use of on-line non-downloadable software for sharing, reporting, maintaining, managing, monitoring and analyzing of medical information in the field of diabetes management; providing on-line non-downloadable software via a website that enables users to share, report, maintain, manage, monitor and analyze medical information in the field of diabetes management; software as a service (SaaS) services featuring software for sharing, reporting, maintaining, managing, monitoring and analyzing of medical information in the field of diabetes managementACTIVE—
044Medical and health care testing services, namely physician testing services for assisting pharmacists and pharmaciesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 28, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2026DOCKASSIGNED TO EXAMINER—
Sep 20, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 17, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance